Daniel A. Erlanson

1 ta ish

Carmot Therapeutics (United States)

1. Twenty years on: the impact of fragments on drug discovery

   Daniel A. Erlanson, Stephen W. Fesik, Roderick E. Hubbard +2

   Sharh maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.206777